Q2 2024 · 13F-HR
venBio Partners LLCholdings as filed
Filed 2024-08-14 · accession 0000905148-24-002220
$231.5M
Reported value
6
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| N69605108 | PHVS | PHARVARIS N V | $80.6M | 34.8% | 4,289,304 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $58.5M | 25.3% | 9,699,925 | Common | SOLE |
| 022307102 | ALMS | ALUMIS INC | $37.6M | 16.2% | 2,826,048 | Common | SOLE |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $31.2M | 13.5% | 1,035,396 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $17.0M | 7.34% | 3,852,470 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $6.6M | 2.84% | 2,434,255 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.